Stewart Jones

Title: Stewart Jones - Innovator in Pharmaceutical Development

Introduction

Stewart Jones is a notable inventor based in Swindon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications. His work focuses on creating effective treatments for serious health conditions.

Latest Patents

Stewart Jones holds a patent for HDAC inhibitor solid state forms. This patent relates to various solid-state forms of N-hydroxy 2-{6-[(6-fluoro-quinolin-2-ylmethyl)-amino]-3-aza-bicyclo[3.1.0]hex-3-yl}pyrimidine-5-carboxamide. The methods of making these solid-state forms are crucial for the preparation of pharmaceutical compositions and dosage forms aimed at treating cancer, immune disorders, and inflammation.

Career Highlights

Stewart is currently associated with Viracta Subsidiary, Inc., where he continues to advance his research and development efforts. His innovative approach has positioned him as a key player in the pharmaceutical industry, contributing to the creation of effective therapeutic solutions.

Collaborations

Stewart collaborates with talented professionals in his field, including Xiaohu Deng and David Slack. These partnerships enhance the research and development process, leading to more robust and effective pharmaceutical innovations.

Conclusion

Stewart Jones exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking work on HDAC inhibitors. His contributions are vital for the advancement of treatments for critical health issues.